pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Lead Candidate · news · pharmadog
← back to Lead Candidate
News mentioning Lead Candidate
103
stories
Jul 20, 26
Scribe aims for $96M IPO to fund clinical push for lipid-lowering genetic meds
fiercebiotech
Jul 17, 26
Dimerix snaps up Mission’s stalled, phase 2-ready kidney disease candidate in $292M deal
fiercebiotech
Jul 16, 26
Chutes & Ladders—Cue lines up new CMO and research head
fiercebiotech
Jul 14, 26
Draig bags another $65M to speed testing of brain drugs
biopharma dive
Jul 6, 26
Gene editing developer Scribe plots an IPO
biopharma dive
Jul 1, 26
Ipsen to scoop up Memo Therapeutics and its kidney infection drug
endpoints
Jun 30, 26
Beeline ups its Series A round for immune drug work
biopharma dive
Jun 29, 26
Evommune's lead drug fails in chronic hives, stock sinks
endpoints
Jun 16, 26
Lilly buys non-opioid pain drugmaker 4E
biopharma dive
Jun 10, 26
Ethyreal starts up with $101M and takes aim at a pair of immune diseases
biopharma dive
Jun 8, 26
City banks nearly $100M for next-gen RNAi drugs
biopharma dive
May 11, 26
Biotech layoffs are easing, but is the worst over?
biopharma dive
Dec 22, 25
Fierce Biotech Fundraising Tracker '26: VitriVax scores $87M; Ansa adds $71.5M series C
fiercebiotech
← prev
page 4 of 4
next →